Sign in

NCT07623551Not yet recruiting

Observational Study on the Causal Architecture of Polycystic Ovary Syndrome (PCOS)

An Observational Data Collection Study to Characterize the Hormonal, Metabolic, and Clinical Architecture of Polycystic Ovary Syndrome in Women Aged 18 to 45: A Global Recruitment Initiative

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

The goal of this observational study is to learn about the causal architecture of Polycystic Ovary Syndrome (PCOS) in women aged 18 to 45. The main questions it aims to answer are: What does the hormonal, metabolic, and clinical architecture of PCOS look like across a diverse global population? Can the causal architecture of PCOS be reconstructed from existing lab results and clinical data? Are there distinct architectural patterns across different groups of women with PCOS? Participants who have been diagnosed with PCOS by a healthcare provider will complete an online questionnaire about their diagnosis, symptoms, clinical history, current treatment, and existing lab results. Participants will also be asked to submit copies of their most recent blood work and lab results. No intervention or treatment is involved. All data is de-identified.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
28 May 2026
Start date
1 Jun 2026
Primary completion date
31 Jul 2026
Lead sponsor
AnnieGuard Corp.
NCT number
NCT07623551

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Jun 2026 to the primary completion date, 31 Jul 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Under 18 years of age
  • Over 45 years of age

Other

  • No confirmed PCOS diagnosis from a licensed healthcare provider
  • Unable or unwilling to provide informed consent

Who the study is looking for

  • Female
  • Aged 18 to 45 years
  • Diagnosed with Polycystic Ovary Syndrome (PCOS) by a licensed healthcare provider
  • Willing to voluntarily share existing lab results and clinical history
  • Able to provide informed consent

Age in the registry: 18 years to 45 years · Sex: Female

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.